# Aurore Pharmaceuticals Private Limited (Unit I) - Inspection Records

Source: https://www.keypedia.com/companies/aurore-pharmaceuticals-private-limited-unit-i/324c0fea-91ef-4166-9a39-208a151fb12f

> Inspection records and compliance data for Aurore Pharmaceuticals Private Limited (Unit I) in Hyderabad, None. Access full analysis and detailed observations.

---

## Details

- Name: Aurore Pharmaceuticals Private Limited (Unit I)
- FEI Number: 3003937580
- City: Hyderabad
- State: None
- Country Name: India
- Address Line 1: Unit-I, Plot Nos. 35,36,38 to 40, 49 to 51, Phase IV, IDA,, Jeedimetla
- Zip Code: None
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1240159 - Aurore Pharmaceuticals Private Limited (Unit I) - 2024-05-31](https://www.keypedia.com/records/fda_inspections/aurore-pharmaceuticals-private-limited-unit-i/068064fa-0020-4498-8f37-a3007bf80525) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 31, 2024
- [483 - Aurore Pharmaceuticals Private Limited (Unit I) - 2024-05-27](https://www.keypedia.com/records/483/aurore-pharmaceuticals-private-limited-unit-i/6a7c3efc-4945-4b60-ab7a-c603a0c3a683) — source: FDA, date: May 27, 2024
- [FDA Inspection 1059153 - Aurore Pharmaceuticals Private Limited (Unit I) - 2018-05-25](https://www.keypedia.com/records/fda_inspections/aurore-pharmaceuticals-private-limited-unit-i/6784c958-3441-4166-a5b1-13049f6436c3) — classification: No Action Indicated (NAI), source: FDA, date: May 25, 2018
- [FDA Inspection 872450 - Aurore Pharmaceuticals Private Limited (Unit I) - 2014-02-07](https://www.keypedia.com/records/fda_inspections/aurore-pharmaceuticals-private-limited-unit-i/bfc4b31f-7a38-49c4-9b6b-2fa123e1b54e) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2014
- [FDA Inspection 699241 - Aurore Pharmaceuticals Private Limited (Unit I) - 2010-10-29](https://www.keypedia.com/records/fda_inspections/aurore-pharmaceuticals-private-limited-unit-i/0ba713e7-b8b9-4fd6-ad2c-47cccc6206d9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 29, 2010

## Related Companies

- [Yuki Gosei Kogyo Co., Ltd.](https://www.keypedia.com/companies/yuki-gosei-kogyo-co-ltd/94411f09-2744-47ca-9250-20774e61824e)
- [Cambridge Isotope Laboratories, Inc.](https://www.keypedia.com/companies/cambridge-isotope-laboratories-inc/bb7d8566-a216-469b-88ac-a3fa0060927e)
- [Cayman Chemical Company, Inc.](https://www.keypedia.com/companies/cayman-chemical-company-inc/8a9655d6-3cec-4e6e-836e-17e9659f3e5b)
- [DDP Specialty Electronic Materials US 9, LLC](https://www.keypedia.com/companies/ddp-specialty-electronic-materials-us-9-llc/bfd7705b-0b03-4c4e-a3d7-d0940e04a868)
- [Piramal Pharma Limited](https://www.keypedia.com/companies/piramal-pharma-limited/c2aa1ac8-a474-4948-84c1-cd848c50558e)
- [Shouguang Fukang Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shouguang-fukang-pharmaceutical-co-ltd/c6836369-cde1-4980-97c8-314af897d7e1)
- [SI Group, Inc.](https://www.keypedia.com/companies/si-group-inc/6f15e9d4-610c-474c-907b-9d9d3b5621f3)
- [ISP Sutton Laboratories](https://www.keypedia.com/companies/isp-sutton-laboratories/27126d09-6823-4e2b-8f31-d8645861af12)
- [Herbamed AG](https://www.keypedia.com/companies/herbamed-ag/d4987d1a-9073-4e45-ba78-0c4fe49241ef)
- [Zaklady Farmaceutyczne Polpharma S.A.](https://www.keypedia.com/companies/zaklady-farmaceutyczne-polpharma-sa/f59abed7-7196-4b5f-ae0e-3286e2e8de39)

## Related Officers

- [Teresa I. Navas](https://www.keypedia.com/people/teresa-i-navas/43f747c0-18c2-4630-bab9-936204aa93aa)